Published in Amyotroph Lateral Scler Other Motor Neuron Disord on December 01, 1999
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res (2007) 1.09
Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J (2011) 0.83
Inhibitory system overstimulation plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis. F1000Res (2016) 0.81
Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutation. J Neurol (2015) 0.76
Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.76
Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve (2015) 0.76
Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. ESPEN J (2013) 0.75
Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases. Front Neurol (2016) 0.75
Gastrointestinal dysfunction in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (1999) 0.75
Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep (2017) 0.75
Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest (2001) 2.35
Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet (2001) 2.23
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol (2009) 1.90
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol (2001) 1.84
Laparoscopic-assisted resection of giant sigmoid lipoma under colonoscopic guidance. Surg Endosc (2002) 1.66
Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A (1992) 1.61
Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest (1999) 1.44
Inflammatory demyelinating neuropathy in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis (CAPD) Perit Dial Int (1998) 1.43
High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis. Rheumatology (Oxford) (2005) 1.41
[Megaloblastic anemia due to inadequate nutrition]. Dtsch Med Wochenschr (1997) 1.39
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol (2000) 1.30
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut (2005) 1.30
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol (2002) 1.28
Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology (2003) 1.24
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest (1996) 1.24
FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet (2004) 1.24
Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol (2004) 1.23
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
Consequences of mutations within the C terminus of the FHL1 gene. Neurology (2009) 1.18
Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Am J Gastroenterol (1994) 1.14
Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol (1995) 1.06
MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens (2001) 1.05
Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol (1996) 1.05
Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05
Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet (2000) 1.05
Gastric emptying following pylorus-preserving Whipple and duodenum-preserving pancreatic head resection in patients with chronic pancreatitis. Am J Surg (1997) 1.05
Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis (2002) 1.03
Focal deficiency of cytochrome-c-oxidase in skeletal muscle of patients with progressive external ophthalmoplegia. Cytochemical-fine-structural study. Virchows Arch A Pathol Anat Histopathol (1983) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
[Granular body myopathy (so-called reducing body myopathy)]. Pathologe (1982) 1.01
Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet (1992) 1.01
Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00
Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant (1999) 1.00
Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet (2004) 1.00
Pseudohypoparathyroidism and hypocalcemic "myopathy". A case report. Klin Wochenschr (1981) 0.99
Fatal lipid storage myopathy with deficiency of cytochrome-c-oxidase and carnitine. A contribution to the combined cytochemical-finestructural identification of cytochrome-c-oxidase in longterm frozen muscle. Virchows Arch A Pathol Anat Histopathol (1983) 0.99
Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl (2000) 0.98
Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol (1996) 0.98
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol (2007) 0.98
A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin. Neurology (1999) 0.97
Nemaline cardiomyopathy in a young adult: an ultraimmunohistochemical study and review of the literature. Ultrastruct Pathol (2001) 0.96
Progressive myoclonus epilepsy and mitochondrial myopathy associated with mutations in the tRNA(Ser(UCN)) gene. Ann Neurol (1998) 0.95
Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol (2003) 0.94
Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology (2000) 0.94
[Reducing body myopathy--ultrastructure and classification (author's transl)]. Virchows Arch A Pathol Anat Histol (1981) 0.93
Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci (1993) 0.93
Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion (2004) 0.92
Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion (2002) 0.91
Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations. Neurology (2006) 0.91
A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology (2000) 0.91
Pavlovian conditioning of taste aversion using a motion sickness paradigm. Psychosom Med (2001) 0.91
Alcoholic beverages produced by alcoholic fermentation but not by distillation are powerful stimulants of gastric acid secretion in humans. Gut (1997) 0.90
Changes of sonographic, magnetic resonance tomographic, electromyographic, and histopathologic findings within a 2-month period of examinations after experimental muscle denervation. Arch Orthop Trauma Surg (1998) 0.90
Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol (1999) 0.89
Effects of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon. Eur J Gastroenterol Hepatol (1995) 0.89
18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp Gerontol (2003) 0.88
Rapidly progredient scoliosis associated with multicore disease. Arch Orthop Trauma Surg (1998) 0.88
Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun (2001) 0.88
Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion (2000) 0.88
Klippel-Trenaunay syndrome with involvement of coecum and rectum: a rare cause of lower gastrointestinal bleeding. Eur J Med Res (2004) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol (1998) 0.88
The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis (2000) 0.87
Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res (2001) 0.86
US findings in the scrotum of extreme mountain bikers. Radiology (2001) 0.86
De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy. Neuromuscul Disord (2002) 0.86
The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. Clin Immunol (2003) 0.86
The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2001) 0.86
Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Dis Esophagus (2004) 0.86
Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol (2004) 0.85
Expression and localization of annexin VII (synexin) in muscle cells. J Cell Sci (1995) 0.85
Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. A cytochemical-ultrastructural study. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 0.85
Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis. Ann Rheum Dis (2005) 0.85
Diagnosis of digital flexor tendon annular pulley disruption: comparison of high frequency ultrasound and MRI. Ultraschall Med (1999) 0.85
Circadian variation of rectal sensitivity and gastrointestinal peptides in healthy volunteers. Neurogastroenterol Motil (2008) 0.85
A specific point mutation in the mitochondrial genome of Caucasians with MELAS. Hum Genet (1991) 0.84
[Quality of life after brachial plexus lesions in adults]. Handchir Mikrochir Plast Chir (2013) 0.84
Metabolic control and effect on secondary complications of diabetes mellitus by pancreatic transplantation. Baillieres Clin Gastroenterol (1989) 0.84
The clinical spectrum of Friedreich's ataxia in German families showing linkage to the FRDA locus on chromosome 9. Clin Investig (1993) 0.83
Mitochondrial myopathies: divergences of genetic deletions, biochemical defects and the clinical syndromes. J Neurol (1990) 0.83
A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Eur J Neurol (2005) 0.83
Adoptive transfer of genetic susceptibility to Crohn's disease. Gut (2004) 0.83
Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome with deficiency of cytochrome-c-oxidase in cardiac and skeletal muscle. An enzymehistochemical--ultra-immunocytochemical--fine structural study in longterm frozen autopsy tissue. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.83
The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin Immunol (2003) 0.83
[Ultrasound contrast agents and prostate cancer]. Radiologe (2005) 0.83